A computed tomography (CT)-derived radiomics approach for predicting primary co-mutations involving TP53 and epidermal growth factor receptor (EGFR) in patients with advanced lung adenocarcinomas (LUAD)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.